Research

Gene Therapy Blocks Peripheral Nerve Damage in Mice

In a new study from Washington University School of Medicine in St. Louis, scientists have blocked the destruction of nerve axons in mice, a step toward helping patients with various neurodegenerative disorders, including peripheral neuropathy. The findings of this report, originally reported by Julia Evangelou Strait, can be found below. Nerve axons serve as the …

Gene Therapy Blocks Peripheral Nerve Damage in Mice Read More »

FPN Welcomes Newest Research Partner in Washington University School of Medicine in St. Louis

The Foundation for Peripheral Neuropathy (FPN) continues to build a network of leading neurological consortium partner clinics.  Starting in January 2019, FPN is pleased to announce the newest research partner added to its consortium of institutions: Washington University School of Medicine in St. Louis. Washington University will join the other five research sites who work …

FPN Welcomes Newest Research Partner in Washington University School of Medicine in St. Louis Read More »

Stem Cell Treatments: A real hope or false promise?

The Foundation for Peripheral Neuropathy receives many inquiries from patients about stem cell treatments for peripheral neuropathy. An article, ‘Snake Oil’ Stem Cell Clinics Peddle False Hope for High Prices recently appeared in The Medium (www.medium.com) on the rise of stem cell treatments for any number of conditions. Is it a real hope or false …

Stem Cell Treatments: A real hope or false promise? Read More »

IMAGINE Study on anti-MAG IgM paraprotein-associated peripheral neuropathy expanding in the US.

The Foundation for Peripheral Neuropathy (FPN) is pleased to announce a new partnership to further research on anti-MAG IgM paraprotein-associated peripheral neuropathy. FPN will be partnering with the IMAGINE study, a global research collaborative focusing on anti-MAG and IgM paraprotein-associated peripheral neuropathy. Thanks to a donation from the Atlantic Philanthropies Director/Employee Designated Gift Fund, FPN …

IMAGINE Study on anti-MAG IgM paraprotein-associated peripheral neuropathy expanding in the US. Read More »

Topiramate as a Disease Altering Therapy for Cryptogenic Sensory Peripheral Neuropathy

NeuroNEXT and the National Institute of Neurological Disorders and Stroke (NINDS) are undergoing a double-blind, placebo clinical trial looking at the effectiveness of treating peripheral neuropathy with the FDA-approved drug, topiramate. This is a 96-week placebo-controlled trial of topiramate at a target dose of 100 mg daily (50 mg twice daily) as a potentially disease …

Topiramate as a Disease Altering Therapy for Cryptogenic Sensory Peripheral Neuropathy Read More »

Hereditary and idiopathic neuropathies

New Discovery May Lead to New Approach to Treating Neuropathy Pain

Blocking the Pathway of Neuropathy Pain An international collaboration between Indiana University in Bloomington and the Turku Center for Biotechnology in Finland made early inroads into a new approach to reducing neuropathy pain. The researchers identified the correlation between the formation of a certain protein in the cell (NOS1AP) and the transmission of neurological pain.  …

New Discovery May Lead to New Approach to Treating Neuropathy Pain Read More »

peripheral neuropathy research

Dr. Sandra Rieger’s Research Could Lead to Advances in Prevention of Peripheral Neuropathy

What do zebrafish have to do with peripheral neuropathy research? In September 2017  , we reported that Dr. Sandra Rieger had received a National Institutes of Health (NIH) research grant to continue her study of nerve regeneration and peripheral neuropathy.   (See MDI Biological Laboratory Scientist Receives Grant to Study Peripheral Neuropathy )  In this study, she noticed a connection between nerve degeneration and an …

Dr. Sandra Rieger’s Research Could Lead to Advances in Prevention of Peripheral Neuropathy Read More »

peripheral neuropathy research

MDI Biological Laboratory Scientist Receives Grant to Study Peripheral Neuropathy Copy

NIH Award Will Support Research by Sandra Rieger, Ph.D., on Nerve Damage Induced by Cancer Chemotherapy                BAR HARBOR, MAINE — The MDI Biological Laboratory has announced that Sandra Rieger, Ph.D., has been awarded a highly competitive grant from the National Cancer Institute, an institute of the National Institutes …

MDI Biological Laboratory Scientist Receives Grant to Study Peripheral Neuropathy Copy Read More »

Orthoses for Children with Charcot-Marie-Tooth Disease

Prescription of foot and ankle orthoses for children with Charcot-Marie-Tooth disease: a review of the evidence Grant Scheffers,  Claire Hiller, Kathryn Refshauge, Joshua Burns Background: Charcot-Marie-Tooth disease (CMT) is the most common inherited peripheral neuropathy and is associated with debilitating lower limb impairments and activity limitations. These impairments and activity limitations are potentially amendable to …

Orthoses for Children with Charcot-Marie-Tooth Disease Read More »

peripheral neuropathy research

MDI Biological Laboratory Scientist Receives Grant to Study Peripheral Neuropathy

NIH Award Will Support Research by Sandra Rieger, Ph.D., on Nerve Damage Induced by Cancer Chemotherapy                BAR HARBOR, MAINE — The MDI Biological Laboratory has announced that Sandra Rieger, Ph.D., has been awarded a highly competitive grant from the National Cancer Institute, an institute of the National Institutes …

MDI Biological Laboratory Scientist Receives Grant to Study Peripheral Neuropathy Read More »

Send this to a friend